LinkedIn image ad examples

Niet elke gesloten incisie heeft hetzelfde risicoprofiel. De combinatie van patiëntgebonden factoren en procedure gerelateerde risico's maakt het niet altijd eenvoudig om te bepalen welke incisie extra aandacht vraagt. De Prevena™ Decision Guide ondersteunt een gestructureerde beoordeling van risico's en helpt bij klinische besluitvorming binnen verschillende chirurgische specialismen. Praktisch, overzichtelijk en direct toepasbaar in de dagelijkse praktijk.

84 études démontrent moins d’infections, de réhospitalisations et de réinterventions. Une méta-analyse multispecialité récente portant sur 84 études a montré que la thérapie par pression négative sur incision fermée est associée à : ✓ 48 % de réduction des infections du site opératoire ✓ 46 % de réduction des complications du site opératoire ✓ 36 % de réduction des réinterventions ✓ 23 % de réduction des réhospitalisations Découvrez les données scientifiques qui sous-tendent ces résultats et le rôle potentiel de Prevena™ dans la chirurgie moderne.

🏆 Double Platinum: Bracco Imaging Earns Its Second Consecutive EcoVadis Platinum Medal! We are thrilled to announce that Bracco Imaging has been awarded the 2026 EcoVadis Platinum Medal—retaining our position in the top 1% of companies assessed worldwide over the last 12 months. This isn't just about maintaining our top-tier standing; it is about measurable, continuous improvement. This year, we raised our overall #sustainability score from 83 to an outstanding 91/100, recording gains across all four assessment categories: 📈 Score Boost (91/100): A testament to our increasingly robust sustainability data, voluntary limited assurance of selected KPIs, and expanded ISO certifications. 🤝 Strengthened Governance & Procurement: Reflecting major advancements in our responsible sourcing and procurement practices across the entire value chain. 🌍 Transparent Impact: This milestone perfectly aligns with the launch of our 2025 Sustainability Report, highlighting nearly 30 years of transparent ESG disclosure. As we look ahead, we remain fully committed to raising the bar even higher—integrating sustainability priorities across our operations to create long-term value for #healthcare and #society. 👉Follow us to stay updated on our sustainability journey and commitment to responsible growth. #EcoVadisPlatinum #Sustainability #Healthcare #DiagnosticImaging #ESG

Unterwegs, im Beruf oder bei sozialen Aktivitäten: Der Peristeen® Analtampon kann Patient:innen mit Stuhlinkontinenz mehr Sicherheit in alltäglichen Situationen bieten.

Für viele Betroffene ist ein verlässlicher Schutz entscheidend. Der Peristeen® Analtampon unterstützt Patient:innen mit Stuhlschmieren oder Stuhlinkontinenz und kann bis zu 12 Stunden Sicherheit bieten.

Veiligheid zonder inperking. Vrijheid met zorg dichtbij. Bloezem biedt luxe wonen voor ouderen met dementie en/of een fysieke zorgvraag.

U hoeft zich niet bezwaard te voelen. Bloezem betekent: zorg dichtbij, mensen om zich heen, eigen ritme. Beoordeeld 9,3 op Zorgkaart NL.

Ready to move beyond “good enough”? Explore next-generation Midmark® Operatory Solutions designed to support efficient workflows, better care experiences and the needs of your dental team.

O Chemo Mouthpiece® é um dispositivo de crioterapia oral clinicamente comprovado para reduzir a ocorrência e a gravidade da mucosite oral induzida por quimioterapia. Procuramos um parceiro de distribuição de dispositivos médicos estabelecido, com experiência em oncologia, para introduzir o Chemo Mouthpiece no Brasil. O Chemo Mouthpiece possui registro como dispositivo médico Classe II no Brasil.

På Dandiags pipettekursus får du praktisk viden om pipetteteknik, vedligeholdelse, fejlfinding og de muligheder, der kan gøre din hverdag i laboratoriet både lettere og mere præcis. Lær at bruge din pipette rigtigt – og få mere ud af den.

En præcis vægt kræver den rigtige vejeteknik. På Dandiags kursus lærer du at veje mere korrekt, forstå fejlkilder og få mere ud af din laboratorievægt.

Patient perspectives are central to ERS 2026, and this year's theme of “United for better breathing” speaks to the commitment we all have to ordinary people, whose lives we positively impact through advances in science across respiratory health and care. This responsibility also means not passing the burden of change onto the people at the other end of it. As a CDP 2025 Climate A List organisation, Chiesi is committed to Net Zero by 2035, 15 years ahead of the European Climate Neutrality target, with these targets validated by Science Based Targets Initiative (SBTi).

ERS 2026 brought into focus the vital role the healthcare industry has to play in climate change. In the case of inhalers, propellants are our single largest source of greenhouse gas emissions. But changing them is our biggest lever. That's why Chiesi is transitioning to a next-generation, low global warming potential, non-PFAS propellant. This reduces the carbon footprint of its pMDIs by up to 90%, bringing them in line with DPI products.

Fill & Finish is one of the most critical stages in biopharmaceutical manufacturing.📋 Every additional handling step increases complexity and requires valuable time, qualified personnel and controlled manufacturing conditions. That is why more manufacturers are evaluating which activities truly add value and which can be reliably outsourced. CG Pharma & Biotech supports Fill & Finish operations with customer-specific process solutions developed through our C-Made product portfolio: 🔹 ready-to-use buffer solutions 🔹 acid and caustic solutions 🔹 salt solutions 🔹 High-Quality Water (AP/WFI) for further processing It is essential to us that our solutions integrate seamlessly into your validated manufacturing processes. We supply you with: ✔️ the required concentration 📦 an optimal packaging concept 💧 your desired fill volume Thereby we help reduce preparation activities, minimise unnecessary open handling, and support efficient GMP manufacturing. How do you optimise efficiency and minimise handling steps within your Fill & Finish operations?

I want to be upfront about this agenda: We built it around an argument. The industry keeps talking about RIM as a technology decision. Which platform, which version, which implementation partner. Meanwhile the benchmark data has been saying the same thing for over a decade: performance doesn't track to the platform. Organizations running the same software land in completely different places. So the interesting question was never "which RIM to implement". Instead, it's why two companies with identical tooling get opposite outcomes, and what the ones who get it right actually did differently. That question shaped the whole programme. The RIM panel is about the distance between technical go-live and business go-live, with people who have run these programmes end to end, including the parts that did not go to plan. The data quality panel asks whether regulatory data is an asset or a liability. The AI panel is deliberately skeptical. Nobody is coming to tell you their transformation went perfectly. That was the brief. Register for free here: https://lnkd.in/eYtr85zN Free, virtual, 18 and 19 November, 10am to 12pm ET. Hosted by Epista Life Science

Patient experience is one of the clearest signals of quality in private healthcare. See where your hospital’s patient experience results stand worldwide.

Are you looking to reduce handling risk and streamline cleaning validation while minimizing production downtime for single-use assemblies? Discover CleanAssure™, a new service for ready-to-use, clean and sterile single-use assemblies.

What does world-class patient advocacy look like? Compare your Net Promoter Score (NPS) and response rates against leading hospitals worldwide.

Are you looking to reduce handling risk and streamline cleaning validation while minimizing production downtime for single-use assemblies? Discover CleanAssure™, a new ISO Class 5 cleanroom service for ready-to-use, clean and sterile single-use assemblies.

La mastocitosi è una neoplasia rara caratterizzata da un accumulo clonale di mastociti e da manifestazioni cliniche variabili, da forme indolenti a aggressive🎗️ Un ruolo centrale è svolto dalle mutazioni del gene KIT, in particolare KIT p.D816V, presente nella maggior parte dei casi di mastocitosi sistemica 🧬 L’impiego di tecniche molecolari ad alta sensibilità e del sequenziamento di nuova generazione ha migliorato la diagnosi, la valutazione prognostica e il monitoraggio delle terapie mirate🔬 Ancora una volta, emerge con chiarezza l’importanza della ricerca molecolare nell’ambito delle malattie rare, che si conferma imprescindibile per costruire un futuro caratterizzato da diagnosi più accurate e terapie sempre più efficaci 🧑🔬 Approfondisci su: https://lnkd.in/ec4Y8FY2 #IstitutoGentili #Mastocitosi #MalattieRare #BiologiaMolecolare #Gentili4Science

Febbraio, mese delle malattie rare, si è appena concluso. Ma il nostro impegno non si ferma qui 💪 Da oggi inauguriamo un nuovo percorso dedicato all’acromegalia, una patologia endocrina rara ancora troppo spesso diagnosticata con ritardo 🩺 Identikit dell’acromegalia 🔍 ✅ È causata da un’eccessiva secrezione di GH, quasi sempre dovuta ad adenomi ipofisari benigni ✅ In Italia ha una prevalenza di circa 7 casi ogni 100.000 abitanti, con una maggiore incidenza nelle donne ✅ Provoca una crescita anomala di tessuti e ossa, con alterazioni evidenti a mani, piedi e lineamenti del volto Prossimamente approfondiremo insieme numerosi aspetti clinici e gestionali di questa malattia rara 🔬 Continuate a seguirci! Approfondisci su: https://lnkd.in/d3DeDGzh #IstitutoGentili #Acromegalia #MalattieRare #Gentili4Science

Waarom meer betalen als goede tandtechniek ook slim geprijsd kan zijn? Met Excent Select kies je voor voorspelbare kwaliteit en een aantrekkelijke prijsstelling. Probeer Select nu zelf. Kies één van drie proefopdrachten met korting en maak kennis met onze Select lijn.

¿Puede la atención de los pacientes verse interrumpida por un incidente de ciberseguridad? La continuidad de la atención, las finanzas y la reputación de una institución de salud pueden estar en juego. El 20 de octubre, la Mesa Ejecutiva del Sector Salud reunirá a líderes de instituciones de salud y representantes del MINSAL, ANCI, CPLT y CENS para conversar sobre protección de datos, ciberseguridad y riesgos financieros, reputacionales y operacionales. Organiza Eniax, con el apoyo de Google Cloud y la colaboración de ProSalud Chile. Eniax ayuda a las instituciones de salud a gestionar su operación ambulatoria con mayor estabilidad, control y capacidad. Evento híbrido: participa online o de forma presencial en Google Santiago, Chile. Cupos presenciales limitados. Conoce el programa e inscríbete 👇

70 anni di storia: cura, accoglienza e dedizione! Il 15 ottobre, in occasione del nostro 70° anniversario vivremo un momento speciale per concludere insieme l’Anno Giubilare della Casa di Cura Madre Fortunata Toniolo. Per ringraziare del cammino percorso in questi anni celebreremo la Santa Messa presieduta dal Cardinale Matteo Maria Zuppi, Arcivescovo di Bologna. Sarà un’occasione per guardare al passato con gratitudine e affidare il presente per continuare a camminare insieme verso il futuro. Vi aspettiamo! 📅 15 ottobre 2026 – ore 18:00 📍 Sala Convegni - Casa di Cura Madre Fortunata Toniolo 📋 Nota legale: L. n. 175/1992, art. 4, c. 2 – Direttore sanitario: Dott.ssa Katiuscia Sponsano